SA
HCA icon

Strategic Advocates’s HCA Healthcare HCA Stock Holding History

Strategic Advocates’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.26K Sell
9
-161
-95% -$81K 0.02% 193
2025
Q4 		$80.6K Hold
170
– – 0.02% 165
2025
Q3 		$72.6K Buy
+170
New +$65.9K 0.02% 179
2024
Q1 		– Sell
-909
Closed -$246K – 147
2023
Q4 		$246K Sell
909
-201
-18% -$49.7K 0.1% 127
2023
Q3 		$273K Buy
+1,110
New +$304K 0.13% 112

Other funds holding HCA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Strategic Advocates's HCA Position: Q1 2026 in Review

Strategic Advocates reduced its HCA Healthcare (HCA) stake by 95% in Q1 2026, selling an estimated $81K and leaving 9 shares worth $4.26K. The position accounts for 0.02% of the portfolio, ranked #193.

Strategic Advocates first reported a position in HCA in Q3 2023 and has held it in 5 quarters since. The position peaked at $273K in Q3 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Strategic Advocates held 9 shares of HCA Healthcare worth $4.26K as of Q1 2026.
  • Strategic Advocates sold 161 HCA Healthcare shares in Q1 2026, an estimated $81K.
  • HCA Healthcare made up 0.02% of Strategic Advocates's portfolio in Q1 2026, its #193 holding.
  • Strategic Advocates first reported a position in HCA Healthcare in Q3 2023 and has held it in 5 quarters since.
  • Strategic Advocates's HCA Healthcare position peaked at $273K in Q3 2023.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.